These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 6443863)

  • 1. [Comparative study of the protective properties of native and sorbed Pseudomonas aeruginosa anatoxins].
    Dziuban NF
    Mikrobiol Zh (1978); 1983; 45(6):85-7. PubMed ID: 6443863
    [No Abstract]   [Full Text] [Related]  

  • 2. [Experimental preventive properties of a complex of Pseudomonas aeruginosa and Clostridium tetani anatoxins].
    Podgornaia LG; Dziuban NF; Kalinichenko NF; Isaeva SIa
    Mikrobiol Zh (1978); 1987; 49(5):55-8. PubMed ID: 3150503
    [No Abstract]   [Full Text] [Related]  

  • 3. [The protective properties of Pseudomonas aeruginosa anatoxin].
    Dziuban NF; Podgornaia LG
    Mikrobiol Zh (1978); 1985; 47(2):83-6. PubMed ID: 3939835
    [No Abstract]   [Full Text] [Related]  

  • 4. Pseudomonas aeruginosa. II. Experimental acellular vaccine of an endotoxin and anatoxin type.
    Bĕlohlávek S; Pavlík V; Rencová J; Stránský V; Nováková L; Sourek J; Výmola F
    J Hyg Epidemiol Microbiol Immunol; 1987; 31(3):343-52. PubMed ID: 3119704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of the common protective antigen (OEP) and toxoids of protease and elastase from Pseudomonas aeruginosa on protection against hemorrhagic pneumonia in mink.
    Honda E; Homma JY; Abe C; Tanamoto K; Noda H; Yanagawa R
    Zentralbl Bakteriol Orig A; 1977; 237(2-3):297-309. PubMed ID: 403712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pseudomonas aeruginosa preparations for active immunization].
    Nazarchuk LV
    Vrach Delo; 1991 Jul; (7):22-7. PubMed ID: 1771827
    [No Abstract]   [Full Text] [Related]  

  • 7. [Evaluation of the specific activity of hyperimmune anti-Pseudomonas aeruginosa human plasma in an experiment].
    Podgornaia LG; Shinkarenko AA; Krokhina MA; Dziuban NF; D'iachenko VF
    Patol Fiziol Eksp Ter; 1987; (2):70-2. PubMed ID: 3112715
    [No Abstract]   [Full Text] [Related]  

  • 8. [Immunoprophylaxis and immunotherapy of infection caused by Pseudomonas aeruginosa: research results and prospects].
    Stanislavskiĭ ES; Joó I
    Zh Mikrobiol Epidemiol Immunobiol; 1983 Jul; (7):22-31. PubMed ID: 6414198
    [No Abstract]   [Full Text] [Related]  

  • 9. Mouse-protection experience with monovalent Pseudomonas aeruginosa vaccine.
    Sourek J; Výmola F; Zelenková L
    Zentralbl Bakteriol A; 1980 Mar; 246(3):353-62. PubMed ID: 6775443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of somatic component of Pseudomonas aeruginosa on protective immunity in experimental mouse burn infection.
    Okada K; Kawaharajo K; Kasai T; Homma JY
    Jpn J Exp Med; 1980 Feb; 50(1):53-61. PubMed ID: 6770131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prophylactic and therapeutic efficacy of immunoglobulin G antibodies to Pseudomonas aeruginosa lipopolysaccharide against murine experimental corneal infection.
    Preston MJ; Gerçeker AA; Koles NL; Pollack M; Pier GB
    Invest Ophthalmol Vis Sci; 1997 Jun; 38(7):1418-25. PubMed ID: 9191605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Immunogenic properties and specificity of pseudomonas aeruginosa polyvalent vaccine].
    Schiller B; Lysakowska E; Owczarska K
    Med Dosw Mikrobiol; 1981; 33(2):91-6. PubMed ID: 6170849
    [No Abstract]   [Full Text] [Related]  

  • 13. [Protective action of various antibody preparations in experimental bacterial sepsis].
    Trautmann M; Brückner O; Hofstaetter T; Seiler FR; Hahn H
    Beitr Infusionther Klin Ernahr; 1982; 9():155-65. PubMed ID: 6816213
    [No Abstract]   [Full Text] [Related]  

  • 14. Application of vaccine technology to prevention of Pseudomonas aeruginosa infections.
    Pier G
    Expert Rev Vaccines; 2005 Oct; 4(5):645-56. PubMed ID: 16221066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Type-specific immunity in pseudomonas diseases.
    Crowder JG; Fisher MW; White A
    J Lab Clin Med; 1972 Jan; 79(1):47-54. PubMed ID: 4621414
    [No Abstract]   [Full Text] [Related]  

  • 16. Active and passive mouse-protecting capacity of Pseudomonas aeruginosa protein vaccines.
    Joó I; Stanislavsky ES; Zhvanetskaya MI; Mashilova GM; Gladus MA
    Acta Microbiol Acad Sci Hung; 1982; 29(4):267-75. PubMed ID: 6821018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Evaluation of humoral immunologic response in rabbits immunized with a slime antigen of Pseudomonas aeruginosa].
    Primavera KS
    Rev Farm Bioquim Univ Sao Paulo; 1976; 14(1):69-83. PubMed ID: 829452
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preparation and assay of horse anti-Pseudomonas serum and -globulin in mice.
    Laborde HF; De Fajardo CL
    Prog Immunobiol Stand; 1971; 5():419-24. PubMed ID: 4633969
    [No Abstract]   [Full Text] [Related]  

  • 19. [The protective properties of the lysosomal form of Pseudomonas aeruginosa anatoxin in a test of its active protection of experimental animals].
    Minukhin VV; Brodinova NS; Mikhaĭlova NA; Ivanova NN; Tsyganenko AIa; Vasil'chenko VN
    Zh Mikrobiol Epidemiol Immunobiol; 1993; (4):69-72. PubMed ID: 8067120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative studies on the protective potential of antisera directed against four antigenic preparations from Pseudomonas aeruginosa.
    Johnston LJ; Syeklocha D
    Can J Microbiol; 1972 Oct; 18(10):1607-11. PubMed ID: 4628185
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.